JP Stock MarketDetailed Quotes

4577 Daito Pharmaceutical

Watchlist
  • 2147
  • -13-0.60%
20min DelayMarket Closed Nov 22 15:30 JST
32.95BMarket Cap10.22P/E (Static)

Daito Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Daito Pharmaceutical Q1 2025 Earnings Date

Currency：JPYOct 11, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
12.68B
--
+4.11%
EPS
--
40.42
--
-6.59%
Analyst Rating
Strong Buy

Jul 23, 2024

Daito Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Oct 11, 20242025/Q112.678B / ----
Apr 12, 20242024/Q310.552B / 12.190B--
Jan 12, 20242024/Q211.932B / 12.122B--
Oct 12, 20232024/Q112.178B / 13.010B--
Jul 14, 20232023/Q410.531B / 10.930B--
DatePeriodRevenue/EstimateEarnings Call
Oct 11, 20242025/Q112.678B / ----
Apr 12, 20242024/Q310.552B / 12.190B--
Jan 12, 20242024/Q211.932B / 12.122B--
Oct 12, 20232024/Q112.178B / 13.010B--
Jul 14, 20232023/Q410.531B / 10.930B--

Unlock Free Earnings Estimates

Daito Pharmaceutical Earnings Reports

  • Daito Pharmaceutical: Supplementary explanatory materials for the first quarter financial results announcement for the fiscal year ending May 2025

    Oct 11 02:00 ET

  • Daito Pharmaceutical: Summary of Financial Results for the 1st Quarter Ending May 2025 [Japanese GAAP] (Consolidated)

    Oct 11 02:00 ET

  • Daito Pharmaceutical: Extraordinary Report

    Sep 2 02:00 ET

  • Daito Pharmaceutical: Confirmation letter

    Aug 30 01:43 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 23, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data